Xiaojian Zhang
- Molecular Biology top 5%
- Cancer Research top 5%
- Pharmacology top 2%
- Epidemiology top 10%
- Oncology top 10%
- Topics
- Enzyme Catalysis and Immobilization (15 papers)Metabolomics and Mass Spectrometry Studies (14 papers)Pharmacogenetics and Drug Metabolism (13 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaojian Zhang
185 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Molecular Biology 1.9k
- Cancer Research 425
- Pharmacology 385
- Epidemiology 367
- Oncology 340
Countries citing papers authored by Xiaojian Zhang
This map shows the geographic impact of Xiaojian Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Zhang more than expected).
Fields of papers citing papers by Xiaojian Zhang
This network shows the impact of papers produced by Xiaojian Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Zhang. The network helps show where Xiaojian Zhang may publish in the future.
Co-authorship network of co-authors of Xiaojian Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Zhang. A scholar is included among the top collaborators of Xiaojian Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Zhang. Xiaojian Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 19 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 22 | |
| 9 | 4 | |
| 10 | Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancerbreakdown → | 121 |
| 11 | 9 | |
| 12 | 9 | |
| 13 | 23 | |
| 14 | 10 | |
| 15 | 18 | |
| 16 | 60 | |
| 17 | 19 | |
| 18 | 12 | |
| 19 | 60 | |
| 20 | 44 |
About Xiaojian Zhang
Xiaojian Zhang is a scholar working on Transplantation, Pharmacology and Molecular Medicine, having authored 195 papers that have together received 4.0k indexed citations. Recurring topics across this work include Enzyme Catalysis and Immobilization (15 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Pharmacogenetics and Drug Metabolism (13 papers). The work is most often cited by research in Molecular Medicine (248 citations), Pharmacology (303 citations) and Cancer Research (425 citations). Xiaojian Zhang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jingli Lü, Zhi‐Qiang Liu, Yu‐Guo Zheng, Xin Tian, Wei Han, Jing Yang, Jian Kang, Haiyang Meng, Weiyan Cheng and Quancheng Kan. Their work appears in journals such as Advanced Functional Materials, Bioresource Technology and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.